Could a common supplement ease jaundice? new trial investigates
NCT ID NCT06236165
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 2 trial tested whether N-acetylcysteine (NAC), a common antioxidant supplement, can help people with jaundice caused by liver or bile duct issues. 44 adults took NAC twice daily for 3 months alongside standard care. Researchers measured changes in antioxidant levels, inflammation, and liver function to see if NAC provides any benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
N-acetylcysteine (NAC)
What this could lead to
If it works, this could point toward a simple, safe supplement to help manage jaundice and improve liver function.
What could go wrong
This is a small, early-phase trial with only 44 participants. Results may not apply to everyone, and the supplement may not significantly improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-HEPATIC JAUNDICE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Pharmacy, Tanta University
Tanta, 31111, Egypt